Annual Report 2024

Culture.
Passion.
Impact.


KEY FIGURES 20241

2.5BN

Revenue in CHF

6.7M

Smiles impacted3

<12 000

Employees

13.7%

Organic revenue growth

82

Employee engagement score

39%

Women in leadership positions4

26%

Core EBIT margin

77

Learning and growth score

40%

Educational activities in low- and middle-income countries

0.95

Dividend2 per share in CHF

100%

Renewable energy

-19%

GHG emissions compared to 2021 (Scope 1+2) t CO2e

1 Figures refer to continuing operations, following the agreement signed in August 2024 to sell the Group’s DrSmile business to Impress Group, which was subsequently completed in September 2024.
2 Subject to AGM approval
3 1 ortho case sold = 1 smile and 2 implants sold = 1 smile
4 According to new calculation methodology


Letter from the Chair and CEO

Chair and CEO

Petra Rumpf, Chair and Guillaume Daniellot, Chief Executive Officer

Dear Reader,

In 2024, we once again performed and transformed, continuing our journey to become the most customercentric and innovative oral care company. We achieved exceptional results, driven by the dedication and passion of our teams, the loyalty of our customers, and the trust of our shareholders.

“6.7 million smiles helped in 2024, 1.1 million more than last year.”

Read more

Together in 2024, we helped 6.7 million people improve their smiles, restore their oral health and, in turn, unlock their potential. This shared purpose and our mission to be the most innovative and customer-focused oral care company in the world continue to inspire us every day.

Despite global headwinds, including geopolitical tensions and macroeconomic uncertainties, our team delivered exceptional organic growth of 13.7% and CHF 2.5 billion in revenue.

Our success comes from staying true to our strategic vision combined, with our agility to capture market opportunities. While market dynamics varied across regions, the Group gained market share in key markets through relentless customer focus, operational adaptability and commitment to innovation and education. Driven by our shared beliefs, our culture, the unwavering passion of our people and their deep commitment to our customers are the forces behind the impactful results we achieve.

We saw exceptional performance in Asia Pacific, where our team capitalized on China’s volume-based procurement (VBP) program to serve more patients. In our largest market, Europe, Middle East and Africa, we achieved substantial growth in both our premium and challenger brands while strengthening ClearCorrect’s market presence. Our North American team demonstrated resilience despite economic challenges, while Latin America could maintain its impressive growth trajectory.

We are particularly proud of our Enterprise Solutions team’s momentum, which led to welcoming several major new dental service organizations (DSOs) to our family. This success validates our approach of providing comprehensive, customized solutions and reinforces our aspiration to be the long-term partner of choice for DSOs seeking sustainable growth.

“2024: A strong year of customer-focused innovation.”

Our strategy centers on customer-driven innovation, and the iEXCEL implant system embodies this commitment by delivering versatility with exceptional simplicity and efficiency. iExcel unifies four implant designs into a single system with one instrument set and prosthetic platform.

In addition, we introduced UN!Q, our cloud-based prosthetic design service. This platform enables dental laboratories to outsource the planning, design and manufacturing of patient-specific implant prosthetics, helping our lab customers resolve resource challenges while creating new revenue streams.

Our innovations transcend technology – they empower clinicians, optimize procedures and transform patient care, one smile at a time. Our Fast Molar workflow innovation is a good example of how to reduce chair time and simplify molar restorations for improved clinical outcomes.

We are expanding access to digital dentistry with SIRIOS, our new intraoral scanner designed for the lowto mid-price segment, bringing precision diagnostics and state-of-the-art treatment monitoring to more practices.

In orthodontics, the ClearCorrect team continued to strengthen our market position by driving enhanced patient outcomes and clinical efficiency, supported by software upgrades and refined packaging.

While innovation drives clinical excellence, education remains the cornerstone of expanding access to high quality oral care. Our partnership with clinicians reached new heights in 2024, delivering 12 000 educational activities globally, with 40% focused in lowand middle-income countries, exceeding our 35% target. A highlight was the landmark ITI World Symposium, which brought together more than 5 500 dental professionals. Together with our strategic partner ITI, we continue to strengthen oral health education and increase access to high quality oral care. At the same time, we are deepening our market presence and building a sustainable foundation for growth aligned with our strategic compass.

“With 12 000 educational activities and an increase from 28% to 40% in low and middleincome countries, we are driving measurable impact in access to oral care.”

Digital leadership is fundamental to our vision of becoming the world’s most customer-centric and innovative oral care company. In 2024, our Straumann AXS digital platform reached key milestones, integrating and simplifying care delivery for both clinicians and patients. This platform exemplifies our dedication to pioneering digital solutions that anticipate and address our industry’s evolving needs. We have successfully launched a seamless surgical-restorative workflow in North America, and we are pleased to share that Straumann AXS will be launched in more regions in 2025.

“We made strong progress in becoming the digitally-powered oral care company.”

We understand that meaningful digital transformation stems from people and mindset, not just technology. This is why, a year ago, we launched EDGE!UP – our platform for digital discovery, expertise sharing, and digital mastery. Since its inception, this initiative has empowered over 1 400 employees to enhance their digital skills through specialized workshops and courses. By cultivating digital fluency and building a digital mindset across our organization, we are building a workforce ready to lead in a digital-first future.

Our success flows from a simple principle: beliefs drive behaviors, behaviors shape culture and culture powers results. Our beliefs and our high-performance culture fuel our achievements in innovation, education, digital transformation and talent attraction.

The strength of our culture shined through again in our weEngage global employee survey, where we achieved a remarkable 92% participation. Our engagement score of 82 places us among the top 10% of global companies, while achieving a high score of 77 in response to ‘I have good opportunities to learn and grow’.

“Culture in action: 82 engagement score places us among leading companies”

These results validate our strategic compass and demonstrate the impact of our high-performance, player-learner culture in action. Our strategic investments in organic growth gained significant momentum this year. Production started at our state-of-the-art China Campus – a substantial milestone in scaling our global operations and being ready for the next volume-based-procurement (VBP) initiative.

We further strengthened our manufacturing footprint by breaking ground on a new Neodent facility in Brazil, scheduled to open in 2026. We also expanded Medentika’s operations in Germany. Both investments bolster our challenger brands and enhance our global production capabilities.

“Significant investments of over CHF 168 million in expanding global footprint and building for growth.”

The strategic divestment of DrSmile sharpened our focus on our core business-to-business orthodontics strategy.

“Powering positive change: building our company sustainably.”

Our sustainability journey reached new milestones with an 8% reduction in Scope 1 and Scope 2 emissions compared to 2023, driven by our shift to renewable energy. We have achieved 98% renewable electricity usage globally, reaching 100% at our manufacturing sites. This keeps us firmly on track for our 2030 and 2040 climate targets. We are also advancing workplace equity, setting a target of 45% women in leadership by 2030, progressing from our current 39% baseline.

Our commitment to positive impact extends beyond environmental goals. Through the newly established Straumann Group Foundation, we are expanding access to oral healthcare for underserved communities and patients worldwide. These combined efforts reflect our broader mission: creating lasting value not only for shareholders but for society as a whole.

As we focus on the future, we also celebrate our past. 2025, marks the 35th anniversary of the Straumann Group as we know it today. A milestone shaped by Thomas Straumann and his vision to focus decades of expertise in material research and precision manufacturing exclusively on dental solutions setting the stage for our transformation from a small family business into a global leader in the dental industry.

“Future-focused strategy.”

As we drive towards the future, the global opportunity remains vast. Our addressable market grew from CHF 19 billion to CHF 20 billion in 2024. Despite this growth, implant penetration rates remain low, offering significant growth potential.

Our industry’s long-term prospects are compelling, supported by powerful demographic tailwinds, increasing affordability, expanded education and growing oral health awareness.

However, challenges such as economic uncertainties, geopolitical risks and disruptive technologies likeartificial intelligence (AI) require adaptability.

Our industry trends review in 2024 helps us navigate key trends, including geopolitical fragmentation, competitive shifts, accelerating AI-driven digital transformation and changing consumer and workforce dynamics.

We enter 2025 from a position of strength. Our dual portfolio of premium and value solutions provides a natural hedge against volatility in consumer confidence. Our broad geographic presence provides resilience against regional economic fluctuations, while our worldwide manufacturing footprint safeguards our supply chain as geopolitical complexities increase. And ultimately, our customer-first mindset, coupled with our agile, player-learner culture, enables us to turn challenges into opportunities and drive sustainable growth by focusing on our customers’ success.

With our diversified portfolio, robust market presence and clear strategic vision, we are confident in our ability to navigate the complexities of the global landscape and continue driving growth and innovation in oral care. Our strong balance sheet and cash flow will allow us to capture opportunities for organic and M&A growth.

As we enter 2025, we remain confident in achieving our twin 2030 ambitions: transforming 10 million smiles annually and reaching CHF 5 billion in revenue, powered by sustained organic growth of at least 10% per year.

Guided by our strategic compass and powered by our high-performance culture, we continue to transform dentistry and unlock the potential of people – one smile at the time. This journey is made possible by the unwavering passion of our teams, the trust of our customers and the continued confidence of our shareholders. Together, we are not just changing smiles. We are transforming lives.

We would like to express our deepest gratitude to our employees for their remarkable dedication, our customers for their loyal partnership and our shareholders for their enduring trust. Your collective support empowers us to pursue our mission and continue to have a profound impact on people’s lives.

Yours sincerely,

Gilbert Achermann signature

Petra Rumpf
Chair of the Board

Guillaume Daniellot signature

Guillaume Daniellot
Chief Executive Officer

19 February 2025

What is our superpower?

“We don’t have the fear of failure (…). We can dare to try. We can be bold because we really have this passion for learning, the agility, the entrepreneurial mindset, the psychological safety… And in my opinion, this makes us unstoppable.”

Daniela Felipucci, Head of Strategic Projects Medical Education


Performance by region1

North America (NAM)

North America
697 M

Revenue in CHF
+3.6% organic revenue

28%

of Group revenue
+1.2% change in CHF


Europe, Middle East, Africa (EMEA)

Europe, Middle East, Africa
1 001 M

Revenue in CHF
+11.3% organic revenue

40%

of Group revenue
+9.0% change in CHF


Latin America (LATAM)

Latin America
217 M

Revenue in CHF
+15.6% organic revenue

9%

of Group revenue
+4.3% change in CHF

Asia Pacific (APAC)

Asia Pacific
588 M

Revenue in CHF
+33.3% organic revenue

23%

of Group revenue
+27.7% change in CHF

1 Figures refer to continuing operations, following the agreement signed in August 2024 to sell the Group’s DrSmile business to Impress Group; the sale was completed in September 2024.


How did my new smile help me unlock my true potential?

“For me, a radiant smile  was more than just an aspiration.”

Karine Perron, patient

Share price development

(Price in CHF)

Share price development

(Price in CHF)


Business Development


In the financial year 2024, we achieved revenue of CHF 2.5 billion and organic revenue growth of 13.7%, or 10.0% growth in Swiss francs after currency headwinds.

Innovation and execution defined 2024 as a standout year for the Group. Advancements in implantology, orthodontics and digital solutions reinforced our position as a leader in dental care in a growing market. The overall addressable market across all business areas grew from CHF 19 billion in 2023 to about CHF 20 billion in 2024.

Our implantology business achieved double-digit revenue growth in both the premium and challenger segments, contributing to the strong 2024 performance. Consequently the Group estimates that its market share in implantology has grown from approximately 32% to 35%. The ClearCorrect and digital solutions businesses also grew double-digit globally, contributing to the strong performance and solidifying the Group’s market position.

Alongside its focus on innovation, execution and organic growth, the Group continued to make significant investments in production capacity, digital transformation and the development of its workforce. Strong top line growth combined with those continued investments translated into an EBIT margin of 27.6% at constant 2023 currency exchange rates .

Despite persistent macroeconomic uncertainties, we continued to make a meaningful global impact, helping 5.6 million smiles in 2023 and growing to 6.7 million smiles in 2024.

Key performance figures1

  2024
Core2
2023
Core2
Revenue (CHF m) 2 503.9 2276.7
Gross profit margin (%) 71.4 74.5
EBIT margin (%) 26.0 28.0
Net profit margin (%) 20.0 21.2

1 Figures refer to continuing operations following the agreement signed in August 2024 to sell the Group’s DrSmile business to Impress Group; the sale was completed in September 2024.
2 To facilitate a like-for-like comparison, the Group presents ‘core’ results in addition to the results reported under IFRS Accounting Standards.

The Business development includes the following chapters
Business performance
Share performance

HOW DO YOU ENVISION DENTISTRY IN 10 YEARS?

“I decided I want to enjoy what I’m doing and stay true to my purpose and enthusiasm.”

Dr. Óscar González-Martín

Sustainability report


100%

Renewable electricity at our own manufacturing

39%

Of leadership positions held by women1

77

Learning and growth score

8 781 T CO₂E

Greenhouse gas emissions
Scope 1

40%

Educational activities in low- and middle-income countries

94%

Sales compliance e-training mean completion rate

6.7 M

Smiles helped

1 432 T CO₂E

Greenhouse gas emissions
Scope 22

1 Based on new calculation methodology
2  Market-based emissions


WHAT ARE THE PAIN POINTS FOR DENTAL LABS?

“You are my thirdparty manufacturing partner I can rely on anytime.”

Jack Marrano,
Director of Signature Prosthetics at Absolute Dental Services,
located in Durham, North Carolina, US

Corporate governance report

The principles, structures, mechanisms and controls by which the Straumann Group is directed and the people who are responsible for their execution.


Compensation report

This report provides a comprehensive overview of the Straumann Group’s compensation principles, practices and delivery framework. It also provides information on the compensation of the general staff, management, Executive Management Board (EMB) and Board of Directors (BoD).


Financial report

The consolidated financial statements of the Straumann Group for the year ended 31 December 2024 were authorized for issue in accordance with a resolution of the Board of Directors on 17 February 2025 and are subject to approval by the annual general meeting on 10 April 2025.

Downloads

Annual Report 2024

Archive